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A B S T R A C T
Background: Mycobacterium yongonense is a recently described novel species belonging to Mycobacterium
avium complex, which is the most prevalent aetiology of non-tuberculous mycobacteria associated with
pulmonary infections, and poses tuberculosis diagnostic challenges in high-burden, resource-con-
strained settings.
Methods: Whole genome shotgun sequencing and comparative microbial genomic analyses were used to
characterize the isolate from a patient diagnosed with multidrug-resistant tuberculosis (MDR-TB) after
relapse.
Results: The genome sequence of the first case of M. yongonense (M. yongonense RT 955-2015) in Tanzania
is presented. Sequence analysis revealed that the RT 955-2015 strain had a high similarity to M.
yongonense 05-1390(T) (98.74%) and Mycobacterium chimaera DSM 44623(T) (98%). Its 16S rRNA showed
similarity to Mycobacterium paraintracellulare KCTC 290849(T) (100%), Mycobacterium intracellulare ATCC
13950(T) (100%), M. chimaera DSM 44623(T) (99.9%), and M. yongonense 05-1390(T) (98%). The strain
exhibited a substantially different rpoB sequence to that of M. yongonense 05-1390 (95.16%), but closely
related to that of M. chimaera DSM 44623(T) (99.86%), M. intracellulare ATCC 13950(T), (99.53%), and M.
paraintracellulare KCTC 290849(T) (99.53%).
Conclusions: In light of the OrthoANI algorithm and phylogenetic analysis, it was concluded that the
isolate was M. yongonense Type II genotype, which is an indication that the patient was misdiagnosed
with TB/MDR-TB and received inappropriate treatment.
© 2018 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Mycobacterium yongonense is a recently reported species from
human specimens in South Korea (Kim et al., 2013a,c). Its 16S rRNA
gene shows a high degree of similarity to members of the
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bacterium intracellulare (99.8%), and it has a distinct rpoB gene
sequence that resembles that of Mycobacterium parascrofulaceum
(Kim et al., 2013a). Other members of MAC include Mycobacterium
timonense, Mycobacterium bouchedurhonense (Ben et al., 2009),
Mycobacterium vulneris, and Mycobacterium colombiense (Tortoli
et al., 2004), as well as Mycobacterium arosiense (van Ingen et al.,
2009). MAC is the most common group of non-tuberculous
mycobacteria (NTM), which are frequently associated with
pulmonary infections in humans, particularly in immune-com-
promised persons (Gordin et al., 1997). A complete genomeciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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previously, with an estimated circular DNA of 5.5 Mb and 5222
protein-coding genes (CDS) (Kim et al., 2013c). Subsequently, two
clinical cases of M. yongonense in Italian patients with lung
infections have been reported (Tortoli et al., 2013). Both strains had
rpoB sequences showing high similarity to that of M. intracellulare
(99.4%), but not to M. parascrofulaceum.
Kim et al. have suggested two distinct genotypes of M.
yongonense based on the rpoB sequence, specifically M. yongonense
Type I genotype with the rpoB gene acquired through horizontal
gene transfer (HGT) from M. parascrofulaceum and M. yongonense
Type II genotype with the M. intracellulare rpoB gene (Kim et al.,
2016). More recently the same authors have provided additional
evidence that the entire M. yongonense Type I rpoBC operon
resulted from a distantly related species of M. parascrofulaceum
(Kim et al., 2017). The authors also revealed that members of M.
yongonense Type I genotype harbour a unique DNA mismatch
repair gene MutS4 family, that potentially serves as a putative
driving force for the suggested HGT between the M. para-
scrofulaceum and M. yongonense Type I genomes through
homologous recombination events (Kim et al., 2017). The
occurrence of NTM in Tanzania has been reported frequently
(Hoza et al., 2016a,b; Mfinanga et al., 2014; Kilale et al., 2016;
Mnyambwa et al., 2017a), but characterization of the isolates has
relied on suboptimal typing methods that have potentially
hindered accurate species identification.
In 2008, the World Health Organization (WHO) endorsed the
molecular tests known as line probe assays (LPA) and, more
recently, the GeneXpert assay for the rapid detection of clinically
resistant TB. MTBDRplus is one of the LPA that has been endorsed
for rapid detection (within 24 h) of multidrug-resistant tuberculo-
sis (MDR-TB) (World Health Organization, 2013). MTBDRplus can
detect drug resistance-conferring mutations for rifampicin and
isoniazid. The MDR-TB treatment guidelines in Tanzania recom-
mend the use of MTBDRplus and a patient should be placed on
MDR-TB treatment if there is proof of rifampicin resistance by LPA,
GeneXpert, or conventional culture-based drug-susceptibility
testing (DST) proportional methods (Ministry of Health, 2012).
The whole genome sequence of M. yongonense isolate RT 955-
2015–the first case of infection to be reported in Tanzania – is
described herein. The organism was isolated from a sputum
specimen of a patient who was diagnosed with MDR-TB by
GenoType MTBDRplus (Hain Lifescience GmbH, Nehren, Germany)
after relapse.
Materials and methods
Culture and drug susceptibility testing
The GenoType MTBDRplus was performed in accordance with
manufacturer’s instructions. Culture and DST were performed in a
contained biosafety level 3 laboratory at the Central TB Reference
Laboratory (CTRL) in Dar es Salaam, Tanzania. The bacterial isolates
were inoculated onto Löwenstein–Jensen (LJ) medium slants and
incubated at 35–37 C, yielding growth in the sixth week. All drug-
sensitivity assays were performed in triplicate and susceptibility to a
particular drug was determined by the standard proportion method,
as recommended by the WHO (World Health Organization, 2009).
Genomic DNA extraction
The genomic DNA was extracted from heat-killed Mycobacterium
tuberculosis by the cetyltrimethylammonium bromide (CTAB)
method, as described in detail elsewhere (van Soolingen et al.,
1991). In summary, bacterial isolates were grown on LJ medium
slants at CTRL. Using a sterile loop, viable colonies were lifted fromDownloaded for Anonymous User (n/a) at Seoul National University Childr
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enediaminetetraacetic acid (EDTA) buffer (TE), pH 8.0, then heat-
killed in a water bath at 80 C for 20 min. This was followed by the
addition of 10 mg/ml lysozyme in each tube and incubation at 37 C
overnight. On the following day, the DNA was extracted with
chloroform–isoamyl alcohol (24:1) and the pellets of genomic DNA
were rehydrated in 80 ml TE and left overnight at 4 C. The gDNA was
then temporarily stored at 20 C before shipping to Kilimanjaro
Clinical Research Institute (KCRI), Moshi, Tanzania for the sequenc-
ing procedure.
Whole genome sequencing
Dual-indexed (24) DNA libraries were constructed by shearing
genomic DNA of approximately 300 bp using the NexteraXT DNA
sample preparation kit according to the manufacturer’s instruc-
tions (Illumina Inc., San Diego, CA, USA). Genomic DNA libraries
were sequenced using a paired-end 2  250 bp protocol (MiSeq
Illumina) at KCRI.
Genome assembly, annotation, and identification
The pre-processed sequencing reads were assembled by means of
SPAdes 3.9.1, using default parameters to generate contigs and
scaffolds. Scaffold-level assembly was evaluated using QUAST with
the reference genome (M. yongonense 05-1390(T)) to generate
summary statistics, such as N50, maximum scaffold length, G + C
content, and others. The assembled scaffold sequences were
ordered using ABACAS (Assefa et al., 2009) with M. yongonense
05-1390 as a reference genome. Gene prediction was performed
using Prodigal and annotation was conducted using a homology
search against the Clusters of Orthologous Groups (COG), eggNOG,
SEED systems, Swiss-Prot, and KEGG databases. A species-level
identification was performed using OrthoANI and 16S rRNA with
98% and 97% as the threshold value, respectively (Chun’s
Bioinformatics Lab (ChunLab)).
Gene content (presence/absence) data were used to generate a
heatmap (ChunLab). The construction of the heatmap utilizes
tetranucleotides of CDS through the whole genome (pan-genome).
The Jaccard coefficient was used to calculate similarities between
genomes based on presence/absence data. Sequence alignment and
syntenic assessment were performed using Mugsy, and an up-to-
date bacterial core genome (UBCG) approximately maximum
likelihood phylogenetic tree was reconstructed using the FastTree
program. The phylogenetic tree was derived from the alignment of
the pseudomolecule with reference sequences. The M. tuberculosis
H37Rv was included as a reference genome representing members
of the Mycobacterium tuberculosis complex (MTBC), while M.
intracellulare ATCC 13950 and M. parascrofulaceum provided
additional evidence for the classification of the isolate into a
specific genotype (Type I or Type II genotype). Additionally, BLAST
analysis against the NCBI RefSeq database was performed.
Multilocus sequence typing
Multilocus sequence typing (MLST) sequences were analyzed
using 10 public M. yongonense genomes from the EzBioCloud
database (ChunLab). The Kruskal algorithm, based on the allelic
distance matrix of the shared loci, was used to construct a
minimum spanning tree. Datasets used and/or analyzed in this
study are freely available at https://www.bioiplug.com/genome/
YongonenseRT9552015Set.
Quality control
The quality and quantity of gDNA were confirmed using a Qubit
2.0 fluorometer (Thermal Fisher Scientific, Waltham, MA USA).en's Hospital from ClinicalKey.com by Elsevier on April 23, 2020.
opyright ©2020. Elsevier Inc. All rights reserved.
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2.3.2) were used to assess the quality of the raw sequence data.
Trimmomatic version 0.36 and FastX-ToolKit (Hannon Lab) were
used to remove Illumina adapter sequences and filter out low quality
sequenced bases and reads. The de novo genome assembly was
validated against a complete genome sequence of M. yongonense 05-
1390. Genome contamination was checked using the ContEst16s
tool and coverage was checked based on bacterial core genes.
Results
Demographic and clinical characteristics of the patient
The patient was a 60-year-old, HIV-negative male living in Dar
es Salaam, Tanzania, who was diagnosed with TB relapse by smear
examination and mycobacterial culture (2015). Additionally, drug
resistance-conferring mutations for rifampicin and isoniazid were
detected using a rapid GenoType MTBDRplus VER 2.0 test.
Subsequently, the conventional phenotypic culture-based DST
(proportion method) on LJ medium was performed and the isolates
were found to be susceptible to all first-line anti-TB drugs. Based on
the MTBDRplus test and medical history, the patient was classified
as having MDR-TB and was hence placed on the MDR-TB treatment
regimen. The patient converted to sputum smear- and culture-
negative status in the third month of MDR-TB treatment, thereby
being considered cured on completion of treatment.
Sequence analysis
MiSeq sequencing generated 400 000 reads, which passed
quality checks with an average of approximately 28  depth
coverage. No evidence of genome contamination was found. The
de novo assembly generated 202 scaffolds containing 402 contigs.
The findings revealed a genome size of 5 528 170 bp with 99.61%Figure 1. Distribution of CDS ba
Downloaded for Anonymous User (n/a) at Seoul National University Ch
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genome has 5331 open reading frames (ORFs), 46 tRNA genes, four
rRNA genes, and one tmRNA. The mean (standard deviation) length
of the CDS was 913.8 (652.3) bp and the median length of the CDS
was 807 bp. The mean (standard deviation) length of the Intergenic
region (IGR) was 137.7 (194.3) bp. The genome of M. yongonense RT
955-2015 has a G + C content of 67.96%. A comparison of predicted
ORFs of M. yongonense RT 955-2015 and that of M. yongonense 05-
1390(T) showed that the two genomes share 4763 ORFs with an
average genome identity of 98.74%. A large number of unshared
genes among M. yongonense genomes was observed. Comparative
functional analysis of genes showed that about one-third of genes
were assigned unknown function and the majority of remaining
genes were assigned to transcription (6.7%), lipid transport and
metabolism (6.4%), energy conversion and production (6.0%),
secondary metabolite biosynthesis, transport and catabolism
(5.5%), replication, and amino acid transport and metabolism
(see Figure 1 and Supplementary material, Table S1 in the online
version, at DOI:10.1016/j.ijid.2018.04.796).
Species identification
Genome similarity analysis of the RT 955-2015 isolate showed
the highest similarity to M. yongonense 05-1390, while both 16S
rRNA and rpoB showed high similarity to M. intracellulare ATCC
13950 and its related members (M. paraintracellulare KCTC 290849
and M. chimaera DSM 44623) (Table 1). Gene content analysis
showing the evolutionary relationship of the isolate suggested that
the RT 955-2015 isolate shares a recent ancestry with M.
yongonense species. The clustering analysis of gene encoding
protein (CDS) content information as expressed by the presence
(blue) and absence (red) of genes is shown in Figure 2A. The RT
955-2015 strain was found to be closely related to M. yongonense
species (I and II) and quite different from M. tuberculosis H37Rv insed on function prediction.
ildren's Hospital from ClinicalKey.com by Elsevier on April 23, 2020.
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Table 1
Similarity values generated by the OrthoANI showing the similarity of isolate RT 955-2015 to the closest members of Mycobacterium avium complex.
Taxonomy name Genome identity (%) 16S rRNA similarity (%) hsp65 similarity (%) rpoB similarity (%) ITS1 similarity (%)
M. yongonense 05-1390(T) 98.74 99.8 99.12 95.16 98.23
M. chimaera DSM 44623(T) 98.00 99.9 99.26 99.86 94.00
M. paraintracellulare KCTC 290849(T) 97.50 100 99.26 99.53 99.29
M. intracellulare ATCC 13950(T) 97.50 100 99.45 99.53 99.29
M. marseillense DSM 43457(T) 92.10 99.8 98.22 97.24 98.27
M. parascrofulaceum ATCC BAA-614(T) 83.83 97.89 94.46 95.07 89.36
Figure 2. Phylogeny based on the presence/absence of genes. (A) Heatmap showing clustering analysis of the gene content among genomes. The pairwise orthologous
relationship is checked through reciprocal UBLAST hits. (B) UPGMA clustering of the strains based on tetranucleotide compositions.
N.P. Mnyambwa et al. / International Journal of Infectious Diseases 71 (2018) 82–88 85the composition of tetranucleotides. Figure 2B shows the same
dendrogram without detailed gene content information. The
UBCG-based maximum likelihood phylogenetic tree also supports
the finding that the RT 955-2015 strain is a member of M.
yongonense (Figure 3). These analyses also reflect the previous
classification of M. yongonense species into two distinct genotypes
(Type I genotype and Type II genotype). BLAST analysis against the
NCBI RefSeq database of all hits and top hits suggested that the
isolate RT 955-2015 was M. yongonense.Figure 3. UBCG-based maximum likelihood phylogenetic tree showing the
evolutionary relationship of Mycobacterium yongonense RT-955-2015.
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A number of single nucleotide polymorphism (SNPs) were
detected in six genes, namely rpoB, rpoC, kasA, katG, inhA, and
pnacA. More polymorphisms (including non-synonymous muta-
tions) were common in the rboB gene (Supplementary material,
Table S2 in the online version, at DOI:10.1016/j.ijid.2018.04.796).
MLST of M. yongonense
A total of 4019 core genes were retrieved from 10 public M.
yongonense genomes and the RT 955-2015 isolate for strain typing,
and a minimum spanning tree was generated (Figure 4). Of the 10
genomes retrieved from public databases, nine were reclassified as
M. yongonense in the EzBioCloud database. The profile was then
used to search the core genes in each genome including the RT 955-
2015 strain. Coloured circles in the tree represent the country
where a strain was isolated and the distance between the nodes
indicates the genetic distance of the isolates. The shorter the
distance the closer the strains are; thus, the RT 955-2015 strain
seems to be very close to the M. yongonense 1099801.4 strain.
Discussion
This study presents the whole genome sequence of a clinical
isolate that was confirmed as M. yongonense RT 955-2015–the firsten's Hospital from ClinicalKey.com by Elsevier on April 23, 2020.
opyright ©2020. Elsevier Inc. All rights reserved.
Figure 4. Minimum spanning tree based on MLST showing genetic distances among 11 strains of Mycobacterium yongonense species. The BioSample accession code of each
strain is provided in parenthesis.
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OrthoANI algorithm, gene content (presence/absence), and com-
plete genome sequence-based phylogenetic analyses, which
further suggested that the M. yongonense RT 955-2015 belongs
to the Type II genotype. Of note, the heatmap and UPGMA
dendrogram, based on the gene presence/absence, showed a
similar strain clustering pattern as the UBCG-based maximum
likelihood phylogenetic tree. Isolate identification based on
similarity analysis of the 16S rRNA gene sequence alone was not
possible due to its high degree of similarity (>99%) with other
members of MAC (Table 1). Previous findings have demonstrated
that the 16S rRNA gene lacks resolution power above 98% similarity
(Lee et al., 2016). As there was no evidence of genome
contamination, the involvement M. yongonense RT 955-2015 as
the causative agent of the disease and that the patient was
misdiagnosed with TB/MDR-TB seems incontrovertible.
The substantial difference between the M. yongonense RT 955-
2015 rpoB sequence and that of M. parascrofulaceum and M.
yongonense 05-1390, while showing high similarity to M. intra-
cellulare and its closely related species (M. chimaera DSM 44623, M.
paraintracellulare KCTC 290849), is additional evidence that the RT
955-2015 strain belongs to the Type II genotype group. Kim et al.
used genome-based phylogenetic analysis to classify M. yongo-
nense species into two distinct genotypes (Type I genotype and
Type II genotype) (Kim et al., 2016), and demonstrated that Type I
genotype has laterally acquired rpoB from M. parascrofulaceum
while Type II genotype possess the M. intracellulare rpoB gene (Kim
et al., 2016, 2017). Kim et al. classified M. yongonense 05-1390, M.
yongonense Asan 36912, and M. yongonense Asan 36527 as
members of Type I genotype, while M. yongonense MOTT36Y
(INT-5) and M. yongonense H4Y (INT-5) were classified as Type II
genotype (Kim et al., 2016). The present study findings for these
strains are consistent with their classification. Furthermore, the
study findings suggest that M. yongonense TKK-01-0059 (formerly
known as Mycobacterium sp TKK-01-0059) from South Africa,
belongs to M. yongonense Type I genotype. The pronounced
difference in a number of unshared genes among the M.
yongonense genomes highlights the possibility of extensive HGT
from outside the cell in these genomes. Evidence of HGT amongDownloaded for Anonymous User (n/a) at Seoul National University Ch
For personal use only. No other uses without permissionNTM members has been described previously (Kim et al., 2016,
2017; Fedrizzi et al., 2017; Kim et al., 2013b).
MLST demonstrated that the M. yongonense RT 955-2015 strain
was closely related to M. yongonense 1099801.4, which was
formerly classified as a member of M. intracellulare, sampled in
Mozambique in 2012. The strain is placed in the same group (Type
II genotype) with M. yongonense RT 955-2015 based on pan-
genome and phylogenetic analysis.
In this study, M. yongonense TKK-01-0059 (formerly Mycobac-
terium sp TKK-01-0059) from South Africa (2009) was also placed
in the Type I genotype. A similar classification has been proposed
by Kim et al., based on the presence of MutS4 and supported by
hsp65 and genome sequence-based phylogenetic analyses (Kim
et al., 2017). The first three stains in the top of the spanning tree
were isolated in the USA and the remaining five isolates were
isolated from South Korea. The clustering of these isolates in the
minimum spanning tree based on the three geographical regions
where they were isolated (Africa, Korea, and the USA) may infer an
important evolutionary relationship among the strains.
M. yongonense is a recently described species (Kim et al., 2013a,
c) of NTM belonging to the MAC members, which are associated
with pulmonary infections in humans. The steady increase in
health complexities and mortality rate caused by several NTM
species have recently been recognized (Yeung et al., 2016) and are
raising a public health concern. The epidemiology and clinical
implications of M. yongonense remain a mystery, as only a few cases
have been described. This can be attributed to the use of
suboptimal diagnostic tests, particularly in developing countries
like Tanzania. The detection of acid-fast bacilli by smear
examination of NTM can result in the misdiagnosis of TB cases
(Hoza et al., 2016a,b; Mfinanga et al., 2014; Kilale et al., 2016;
Mnyambwa et al., 2017a), which normally do not respond to anti-
TB drugs, thereby leading to classification as MDR-TB (Lu et al.,
2016; Shahraki et al., 2015). Most of the MAC members are
naturally resistant to anti-TB drugs (Shahraki et al., 2015;
Mpagama et al., 2013), which leads to the unnecessary adminis-
tration of toxic second-line anti-TB treatments, thereby increasing
the risk of the evolution of drug resistance. Thus, proper tests are
needed for an effective healthcare system, providing criticalildren's Hospital from ClinicalKey.com by Elsevier on April 23, 2020.
. Copyright ©2020. Elsevier Inc. All rights reserved.
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a particular health condition. Such diagnostic tests should also help
to address epidemiological concerns regarding the M. yongonense
species and other underreported members of NTM. SNP-based
phylogenetic analysis targeting five genes (dnaA, deaD, argH, recF,
and hsp65) identified potential diagnostic biomarkers specific for
M. yongonense (Kim et al., 2016).
It is estimated that between 7% and 12% of the adult population
has been previously infected with MAC, but the rate of the disease
varies significantly by geographic region (Gordin et al., 1997;
Benson, 1994). MAC disease is typically prevalent in patients with
compromised immune systems (Gordin et al., 1997). A high
incidence rate, between 20% and 40%, has been reported in patients
with severely low CD4 cell counts associated with HIV infection,
especially when there is an ineffective antiretroviral treatment or
chemoprophylaxis (Gordin et al., 1997). MAC infections have been
reported to cause serious disease in HIV patients globally (Gordin
et al., 1997; Kwak et al., 2017), and evidence of such mycobacterial
infections has been reported in Tanzania (Crump et al., 2009).
Although the GenoType MTBDRplus assay is designed to detect
common resistance mutations of the rpoB gene for rifampicin and
katG and inhA for isoniazid in MTBC strains (Lacoma et al., 2008),
sequence analysis of M. yongonense RT 955-2015 revealed a
catalogue of non-synonymous mutations in the same genes and in
three other genes, namely rpoC, kasA, and pnacA. Pyrazinamide
resistance-conferring mutations are known to occur in the pnacA
gene, while mutations in the rpoC gene are associated with
resistance to rifampicin in MTBC (Mnyambwa et al., 2017b).
Although evidence of genetic markers that are known to cause
drug resistance in MTB strains are provided here, it remains a
mystery whether these genetic signatures play the same role in M.
yongonense.
In conclusion, sequence analysis suggests that the isolate RT
955-2015 is M. yongonense Type II genotype, a member of MAC, and
this is the first detected case in Tanzania. These findings strongly
affirm the hypothesis that the condition was misdiagnosed as TB/
MDR-TB and that the patient received inappropriate treatments.
This finding highlights the need for accurate diagnostic assays to
ensure the effective use of drugs and to minimize the risk of the
development of drug resistance and worsening of the patient’s
health condition.
This whole genome shotgun project has been deposited at
DDBJ/ENA/GenBank under the accession number PSQD00000000
and assigned the name Mycobacterium yongonense RT 955-2015.
The version described in this paper is version PSQD01000000.
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